256 related articles for article (PubMed ID: 11414476)
1. Tumor suppressor loss in pituitary tumors.
Alexander JM
Brain Pathol; 2001 Jul; 11(3):342-55. PubMed ID: 11414476
[TBL] [Abstract][Full Text] [Related]
2. Screening for MEN1 tumor suppressor gene mutations in sporadic pituitary tumors.
Evans CO; Brown MR; Parks JS; Oyesiku NM
J Endocrinol Invest; 2000 May; 23(5):304-9. PubMed ID: 10882148
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas.
Nam DH; Song SY; Park K; Kim MH; Suh YL; Lee JI; Kim JS; Hong SC; Shin HJ; Park K; Eoh W; Kim JH
Exp Mol Med; 2001 Sep; 33(3):111-6. PubMed ID: 11642545
[TBL] [Abstract][Full Text] [Related]
5. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
[TBL] [Abstract][Full Text] [Related]
6. [Molecular genetic changes in hypophyseal adenomas].
Mennel HD
Strahlenther Onkol; 2001 Jul; 177(7):373-4. PubMed ID: 11505626
[No Abstract] [Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of the men1 tumor suppressor gene in sporadic pituitary tumors.
Prezant TR; Levine J; Melmed S
J Clin Endocrinol Metab; 1998 Apr; 83(4):1388-91. PubMed ID: 9543172
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the MEN1 gene in sporadic pituitary adenomas from Japanese patients.
Fukino K; Kitamura Y; Sanno N; Teramoto A; Emi M
Cancer Lett; 1999 Sep; 144(1):85-92. PubMed ID: 10503881
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
11. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas.
Asteria C; Anagni M; Persani L; Beck-Peccoz P
J Endocrinol Invest; 2001 Nov; 24(10):796-801. PubMed ID: 11765049
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors in the development of pituitary adenomas.
Vandeva S; Tichomirowa MA; Zacharieva S; Daly AF; Beckers A
Endocr Dev; 2010; 17():121-133. PubMed ID: 19955762
[TBL] [Abstract][Full Text] [Related]
14. [Familial pituitary adenomas].
Burlacu MC; Tichomirowa M; Daly A; Beckers A
Presse Med; 2009 Jan; 38(1):112-6. PubMed ID: 18990538
[TBL] [Abstract][Full Text] [Related]
15. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic features of familial pituitary adenomas.
Daly AF; Jaffrain-Rea ML; Beckers A
Horm Metab Res; 2005 Jun; 37(6):347-54. PubMed ID: 16001326
[TBL] [Abstract][Full Text] [Related]
18. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features.
Shintani Y; Yoshimoto K; Horie H; Sano T; Kanesaki Y; Hosoi E; Yokogoshi Y; Bando H; Iwahana H; Kannuki S
Endocr J; 1995 Jun; 42(3):331-40. PubMed ID: 7670561
[TBL] [Abstract][Full Text] [Related]
19. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
20. [Genetics of familial pituitary adenomas].
Beckers A; Jaffrain-Rea ML; Daly AE
Bull Acad Natl Med; 2009 Oct; 193(7):1557-70; discussion 1570-1. PubMed ID: 20669636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
